- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
-
Comparing Medicine’s Cost and Effectiveness
-
19 'Bathwater Babies' and 20 'Dogs with Fleas' Stocks for the Week
-
Create Your Own Diagnostics ETF
-
Hedge Fund Tracking: Farallon Capital Management (Thomas Steyer), Q3 2008
-
Best and Worst Performing Stocks on Earnings
-
Be Selective with Medical Device Companies
-
Cepheid: Stock Plunge Presents Buy Opportunity
-
Second Quarter Earnings Season: Biggest Winners and Losers
-
Bernanke, the Greatest Speculator - Fast Money (6/25/08)
-
Cepheid Takes Hit on False MRSA Testing Claim
-
Last Year's Best Stocks Have Been This Year's Worst
-
Tuesday's Options Report: XLF, AIG, ALB, THRX, SGP, CPHD, IGT, PDE
-
2007's Best, Worst Performers Faring Poorly in 2008
-
Cepheid: Is the MRSA Infection an Investment Opportunity?
-
Can Cepheid Power Past $25?
-
Time to Buy Molecular Diagnostics Company Cepheid
-
Four Molecular Diagnostics Companies With An Edge
-
FDA Approves Cepheid’s Test For Infectious Bacteria
-
Neurochem Announcement Lowers Alzhemed Expectations - Barron's
-
Cepheid's Buyout Attractions are Overrated - Barron's
-
Veteran's Administration Contractors: A Good Investment - Barron's
-
Biotech Day in Review: FluMist from MedImmune Outperforms Injected Vaccine
-
Biotech Stocks Day-in-Review: Lilly Drug Effective In Pancreatic Cancer